Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza.

Stepanova, Ekaterina; Isakova-Sivak, Irina; Rudenko, Larisa

Stepanova, Ekaterina; Isakova-Sivak, Irina; Rudenko, Larisa.

Stepanova E; Department of Virology, Institute of Experimental Medicine, Saint Petersburg, Russia.
Isakova-Sivak I; Department of Virology, Institute of Experimental Medicine, Saint Petersburg, Russia.
Rudenko L; Department of Virology, Institute of Experimental Medicine, Saint Petersburg, Russia.

Expert Rev Vaccines ; 21(11): 1533-1535, 2022 Nov.

Article in English | MEDLINE | ID: covidwho-2017400

Subject(s)

COVID-19; Influenza Vaccines; Influenza, Human; Humans; SARS-CoV-2; COVID-19 Vaccines; Influenza, Human/prevention & control; Vaccines, Combined; COVID-19/prevention & control

Keywords

COVID-19; Influenza; SARS-CoV-2; bivalent vaccine; coinfection; viral vectored vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Expert Rev Vaccines Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: 14760584.2022.2117692

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google